Jaime Leandro Foundation For Therapeutic Cancer Vaccines
| Fiscal year | Revenue | Expenses | Net | Reserve mo. | Staff % |
|---|---|---|---|---|---|
| 2021 | 335,642 | 416,192 | −80,550 | -2.3 | 0% |
| 2022 | 1,344,079 | 1,279,455 | 64,624 | -0.1 | 0% |
| 2023 | 2,489,623 | 2,330,695 | 158,928 | 0.7 | 0% |
In its most recent public year (2023), this organization brought in $158,928 more than it spent. Its reserves stood at about 0.7 months of spending, up from -2.3 in 2021. Staff pay was 0% of spending.
Reserve months = net assets ÷ average monthly spending; net assets count everything the organization owns beyond its debts — buildings and donor-restricted funds included, not just cash. Staff pay = salaries, wages, and officer compensation; it excludes benefits and payroll taxes. The IRS releases this data years after the fact — this organization's newest public year is 2023. Years refer to the calendar year in which the organization's fiscal year ended. Short-form filers do not publicly report donor-restricted balances or staffing costs. Source filings
Jaime Leandro Foundation For Therapeutic Cancer Vaccines's IRS filings as a feed — one entry per filing year, through 2023. Add the address to any feed reader; in Slack, send /feed subscribe with it (pasting the link alone won't subscribe). How this feed works